image
Trevi Therapeutics, Inc. TRVI
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 6.145
-0.824 %
$ 594 M
Market Cap
-12.81
P/E
Price Target Average
17.17%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
18.92%
Net Income Estimate
29.45%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Trevi Therapeutics, Inc.
image
Wall Street analysts predict an average 1-year price target for TRVI of $7.2 , with forecasts ranging from a low of $6 to a high of $12 .
TRVI Lowest Price Target Wall Street Target
6 USD -2.36%
TRVI Average Price Target Wall Street Target
7.2 USD 17.17%
TRVI Highest Price Target Wall Street Target
12 USD 95.28%
Price
Max Price Target
Min Price Target
Average Price Target
1212111110109988776655443322Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart TRVI

image
$200.0m$200.0m$180.0m$180.0m$160.0m$160.0m$140.0m$140.0m$120.0m$120.0m$100.0m$100.0m$80.0m$80.0m$60.0m$60.0m$40.0m$40.0m$20.0m$20.0m$0.0$0.020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart TRVI

image
$0.0$0.0($5.0m)($5.0m)($10.0m)($10.0m)($15.0m)($15.0m)($20.0m)($20.0m)($25.0m)($25.0m)($30.0m)($30.0m)($35.0m)($35.0m)($40.0m)($40.0m)($45.0m)($45.0m)($50.0m)($50.0m)20232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart TRVI

image
$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)($120.0m)($120.0m)20232023202420242025202520262026202720272028202820292029